相关实验视频

Updated: Sep 8, 2025

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature

Published on: December 26, 2017

在糖尿病治疗中新兴的基于纳米技术的疗法:最近的发展和未来的意见

Aniket Bhardwaj¹, Saurabh Verma¹, Anukrati Agnihotri²

¹Centre for Industrial Pharmacy, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India, 201301.

Drug development and industrial pharmacy

|August 14, 2025

概括

纳米技术为糖尿病提供先进的药物输送,改善药理动力学和血糖控制. 在临床应用方面仍然存在挑战,但纳米疗法在糖尿病管理方面具有变革性的潜力.

科学领域:

生物医学工程生物医学工程
材料科学材料科学材料科学
药理学药理学是指药理学的学科.

背景情况:

糖尿病是一种慢性代谢障碍,其特征是高血糖.
传统的糖尿病治疗方法在有效性,生物可用性和剂量频率方面存在局限性.
纳米技术为增强药物输送和治疗干预提供了新的平台.

研究的目的:

批判性地分析纳米技术在糖尿病管理中的进展.
阐明基于纳米技术的糖尿病治疗的作用机制.
审查纳米药物治疗糖尿病的治疗应用和潜力.

主要方法:

对基于纳米技术的糖尿病治疗方法的临床前和临床研究的审查.
分析各种纳米配方,包括纳米颗粒,纳米囊,体和固体脂质纳米颗粒.
纳米输送系统提供的药理动力学和药理动力学改进的评估.

主要成果:

像glipizide纳米颗粒和metformin纳米囊这样的纳米配方在临床前模型中显示出改善的药理动力学和治疗疗效.
纳米技术提高了口服生物可用性,并扩大了血糖控制,减少了剂量频率.
体和固体脂质纳米颗粒显示出克服吸收和酶降解障碍的潜力.

结论:

纳米技术为糖尿病管理提供了一个革命性的方法,与传统方法相比,它具有显著的优势.
需要进一步的研究来应对生物相容性,可扩展性和临床翻译的监管批准等挑战.
跨学科的合作对于提炼纳米疗法以安全有效治疗糖尿病至关重要.

关键词:

屏障屏障是一种障碍.糖尿病糖尿病糖尿病配方配方是一种配方.纳米技术纳米技术治疗方法治疗方法

更多相关视频

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

相关概念视频

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...